SER
Serina Therapeutics Inc
NYSE MKT: SER · HEALTHCARE · BIOTECHNOLOGY
$1.83
-1.08% today
Updated 2026-04-29
Market cap
$27.26M
P/E ratio
—
P/S ratio
209.73x
EPS (TTM)
$-1.91
Dividend yield
—
52W range
$1 – $8
Volume
4.0M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C4.0
Quality
C2.5
Profitability
F4.0
Valuation
C5/9
Piotroski F-Score
Moderate
-20.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$11.00
+501.09%
12-Month target
—
—
Intrinsic (DCF)
$1.49
Margin of safety
-24.83%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 154.90% QoQ
Risks
- Altman Z -20.40 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-6.09M
- 24.83% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $500000.00 | $3.15M | $56000.00 | $130000.00 | $130000.00 |
| Net income | $-2.68M | $5.27M | $-11.14M | $-19.18M | $-3.34M |
| EPS | — | — | — | — | $-1.91 |
| Free cash flow | $-2.09M | $-2.98M | $-17.16M | $-18.01M | $-6.09M |
| Profit margin | -536.42% | 167.11% | -19,894.64% | -14,755.38% | — |
Peer comparison
Smart narrative
Serina Therapeutics Inc trades at $1.83. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -20.40, it sits in the distress. TTM revenue stands at $130000.00. Our DCF model estimates intrinsic value at $1.49.
Frequently asked questions
What is Serina Therapeutics Inc's stock price?
Serina Therapeutics Inc (SER) trades at $1.83.
Is Serina Therapeutics Inc overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell). DCF value $1.49.
What is the price target of Serina Therapeutics Inc (SER)?
The analyst target price is $11.00, representing +501.1% upside from the current price of $1.83.
What is the intrinsic value of Serina Therapeutics Inc (SER)?
Based on our DCF model, intrinsic value is $1.49, a -24.8% margin of safety versus $1.83.
What is Serina Therapeutics Inc's revenue?
TTM revenue is $130000.00.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
-20.40 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio209.73x
ROE-8,159.00%
Beta0.10
50D MA$1.92
200D MA$3.61
Shares out0.01B
Float0.01B
Short ratio—
Avg volume4.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—